These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8286092)

  • 21. A distinctive melanocytic lesion associated with melanoma-prone dysplastic naevus syndrome: the hybrid naevus.
    Schubert C; Parwaresch R; Rudolph P
    Virchows Arch; 2001 Feb; 438(2):166-72. PubMed ID: 11253119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-pathological impact of fibroplasia in melanocytic nevi: a critical revision of 209 cases.
    Cesinaro AM
    APMIS; 2012 Aug; 120(8):658-65. PubMed ID: 22779689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acral melanocytic neoplasms: a histologic analysis of 158 lesions.
    Boyd AS; Rapini RP
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):740-5. PubMed ID: 7929919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precursors to melanoma and their mimics: nevi of special sites.
    Elder DE
    Mod Pathol; 2006 Feb; 19 Suppl 2():S4-20. PubMed ID: 16446715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine structural characterization of melanosomes in dysplastic nevi.
    Takahashi H; Horikoshi T; Jimbow K
    Cancer; 1985 Jul; 56(1):111-23. PubMed ID: 4005780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
    Duray PH; Ernstoff MS
    Arch Dermatol; 1987 Jan; 123(1):80-4. PubMed ID: 3800426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi.
    Pulitzer DR; Martin PC; Cohen AP; Reed RJ
    Am J Surg Pathol; 1991 Dec; 15(12):1111-22. PubMed ID: 1746678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origin of cutaneous melanoma in a congenital dysplastic nevus spilus.
    Rhodes AR; Mihm MC
    Arch Dermatol; 1990 Apr; 126(4):500-5. PubMed ID: 2321995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Proof of a Clinical Concept: Expression of Estrogen Alpha-, Beta-Receptors and G Protein-Coupled Estrogen Receptor 1 (GPER) in Histologically Assessed Common Nevi, Dysplastic Nevi and Melanomas.
    Spałkowska M; Dyduch G; Broniatowska E; Damiani G; Wojas-Pelc A
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833446
    [No Abstract]   [Full Text] [Related]  

  • 31. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
    Smoller BR; McNutt NS; Hsu A
    Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
    Xavier-Junior JCC; Ocanha-Xavier JP
    Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Clark/dysplastic" nevi with florid fibroplasia associated with pseudomelanomatous features.
    Ko CJ; Bolognia JL; Glusac EJ
    J Am Acad Dermatol; 2011 Feb; 64(2):346-51. PubMed ID: 21238828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
    Bruijn JA; Berwick M; Mihm MC; Barnhill RL
    J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased epidermal growth factor receptors in melanocytic lesions.
    Ellis DL; King LE; Nanney LB
    J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 and D3 expression in melanocytic skin lesions.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
    Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dysplastic melanocytic nevus].
    Bierhoff E
    Pathologe; 2015 Feb; 36(1):46-50, 52. PubMed ID: 25591417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.